
AI Digest · House panel hears how VA would offer psychedelic care if FDA approves it
Kalshi traders heavily favor no FDA approval of any psychedelic drug this year, and approval lost ground this week. A House Veterans Affairs subcommittee questioned Trump administration officials on Wednesday about whether the VA could offer these treatments if the FDA approves them. A VA adviser said the agency has identified 10 initial sites. Drug developer Helus Pharma said its psychedelic drug HLP003 eased major depression in a late-stage trial on Monday. The study also reported a number of serious adverse events, which raised safety questions.